Canada · Health Canada Drug Product Database
MYLAN-ATORVASTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85839
- DIN
- 02373238
- Form
- Tablet
- Company as listed by source
- MYLAN PHARMACEUTICALS ULC
- Source status
- Cancelled Post Market (2016-05-20)
- Source last updated
- 2026-06-16
Source-listed ingredients
- ATORVASTATIN (ATORVASTATIN CALCIUM) — 40 MG
These values do not establish equivalence or a dose recommendation.
Packages
- 90/500
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →